Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 1
1977 1
1978 1
1979 1
1980 1
1982 1
1983 2
1984 1
1985 1
1986 2
1987 1
1988 2
1992 1
1995 4
1996 1
1997 1
1998 1
1999 4
2000 2
2001 4
2002 3
2003 5
2004 2
2005 3
2006 2
2007 4
2008 5
2009 3
2010 2
2011 1
2012 2
2013 3
2015 2
2016 3
2017 2
2018 2
2020 1
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

76 results
Results by year
Filters applied: . Clear all
Page 1
Clinical pharmacology, efficacy and safety of atazanavir: a review.
Bentué-Ferrer D, Arvieux C, Tribut O, Ruffault A, Bellissant E. Bentué-Ferrer D, et al. Among authors: ruffault a. Expert Opin Drug Metab Toxicol. 2009 Nov;5(11):1455-68. doi: 10.1517/17425250903321514. Expert Opin Drug Metab Toxicol. 2009. PMID: 19863454 Review.
Exercise-Based Injury Prevention in High-Level and Professional Athletes: Narrative Review and Proposed Standard Operating Procedure for Future Lockdown-Like Contexts After COVID-19.
Martens G, Delvaux F, Forthomme B, Kaux JF, Urhausen A, Bieuzen F, Leclerc S, Winkler L, Brocherie F, Nedelec M, Morales-Artacho AJ, Ruffault A, Macquet AC, Guilhem G, Hannouche D, Tscholl PM, Seil R, Edouard P, Croisier JL. Martens G, et al. Among authors: ruffault a. Front Sports Act Living. 2021 Dec 17;3:745765. doi: 10.3389/fspor.2021.745765. eCollection 2021. Front Sports Act Living. 2021. PMID: 34977567 Free PMC article. Review.
Tipranavir-ritonavir genotypic resistance score in protease inhibitor-experienced patients.
Marcelin AG, Masquelier B, Descamps D, Izopet J, Charpentier C, Alloui C, Bouvier-Alias M, Signori-Schmuck A, Montes B, Chaix ML, Amiel C, Santos GD, Ruffault A, Barin F, Peytavin G, Lavignon M, Flandre P, Calvez V. Marcelin AG, et al. Among authors: ruffault a. Antimicrob Agents Chemother. 2008 Sep;52(9):3237-43. doi: 10.1128/AAC.00133-08. Epub 2008 Jul 14. Antimicrob Agents Chemother. 2008. PMID: 18625773 Free PMC article.
Clinically validated mutation scores for HIV-1 resistance to fosamprenavir/ritonavir.
Masquelier B, Assoumou KL, Descamps D, Bocket L, Cottalorda J, Ruffault A, Marcelin AG, Morand-Joubert L, Tamalet C, Charpentier C, Peytavin G, Antoun Z, Brun-Vézinet F, Costagliola D; ANRS Resistance Study Group. Masquelier B, et al. Among authors: ruffault a. J Antimicrob Chemother. 2008 Jun;61(6):1362-8. doi: 10.1093/jac/dkn127. Epub 2008 Apr 4. J Antimicrob Chemother. 2008. PMID: 18390885
Algorithm-based prediction of HIV-1 subtype D coreceptor use.
Dina J, Raymond S, Maillard A, Le Guillou-Guillemette H, Rodalec A, Beby-Defaux A, Giraudeau G, Vallet S, Mourez T, Payan C, Vabret A, Ruffault A, Ferre V, Izopet J, Plantier JC. Dina J, et al. Among authors: ruffault a. J Clin Microbiol. 2013 Sep;51(9):3087-9. doi: 10.1128/JCM.00798-13. Epub 2013 Jun 26. J Clin Microbiol. 2013. PMID: 23804380 Free PMC article.
76 results